Elisabeth Crönert-Bendell
Corporate Officer/Principal bei RHYTHM PHARMACEUTICALS, INC.
Aktive Positionen von Elisabeth Crönert-Bendell
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.04.2021 | - |
Karriereverlauf von Elisabeth Crönert-Bendell
Ehemalige bekannte Positionen von Elisabeth Crönert-Bendell
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SANOFI | Corporate Officer/Principal | - | - |
Kyowa Kirin International Plc
 Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Corporate Officer/Principal | - | - |
Ausbildung von Elisabeth Crönert-Bendell
| INSEAD | Masters Business Admin |
Statistik
International
| Frankreich | 3 |
| Vereinigte Staaten | 2 |
| Vereinigtes Königreich | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| SANOFI | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Health Technology |
